/
Mitiglinide calcium is a novel oral antidiabetic agent acting as a rapid-acting insulin secretagogue. It functions by stimulating pancreatic beta cells to release insulin in response to glucose, specifically targeting postprandial hyperglycemia. The compound features a unique chemical structure with the molecular formula C21H24CaN2O8 and CAS number 195709-78-9. Its synthesis typically involves complex organic coupling reactions followed by calcium salt formation to ensure stability.
Strict clinical monitoring is required to prevent hypoglycemia, particularly in elderly or renal-impaired patients. Storage must be maintained in a cool, dry place away from direct sunlight to preserve chemical integrity. Patients should avoid alcohol consumption during treatment to reduce adverse metabolic risks.